Timothy J. Miller, Ph.D., joined Abeona as President and Chief Executive Officer in 2013 and transitioned to President and Chief Scientific Officer in April 2018, bringing 16 years of experience in scientific research, product development, regulatory and clinical operations, with a focus on transitioning novel biotherapeutics through pre-clinical phases and into Phase 1 and 2 human clinical trials. Dr. Miller served as President and CEO of Red5 Pharmaceuticals from 2013 to 2015 and was Vice President of Business Development at BioEnterprise Inc. in 2015. Prior to Red5 Pharmaceuticals, he served as Senior Director of Product Development at SironRX Therapeutics from 2010 to 2013. Dr. Miller also held various positions at several companies focusing on gene therapy and regenerative medicine from 1996 to 2010. He earned his Ph.D. in pharmacology with a focus on gene therapy and cystic fibrosis from Case Western University. Dr. Miller also holds a B.S. in biology and M.S. in molecular biology from John Carroll University in Cleveland.